Trial Profile
A Phase 2 Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs BZL 101 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2011 Planned End Date changed from 1 Jun 2013 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 06 Jun 2011 Planned initiation date changed from 1 Jul 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 09 Dec 2009 Planned initiation date changed from 1 Apr 2010 to 1 Jul 2010 as reported by ClinicalTrials.gov.